Search Results
May 8, 2026, 3:51 PM
Development of an animal model that recapitulates the progression of FSHD in humans, and possible activity of T & B Cells.
May 8, 2026, 3:37 PM
Histone Therapeutics is making progress with 3R-ON technology.
Connect with us on social media